CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

Keyphrases

• Randomized Controlled Trial 100%
• Inflammatory Bowel Disease 100%
• Core Outcome Set 100%
• International Consensus 100%
• Symptomatic Remission 66%
• Patient-reported Outcomes 66%
• Ulcerative Colitis 66%
• Fecal Calprotectin 66%
• Crohn's Colitis 66%
• Outcome Domains 66%
• Medical Experts 66%
• Abdominal Pain 33%
• Quality of Life 33%
• Outcome Quality 33%
• Systematic Literature Review 33%
• Safety Outcomes 33%
• Endoscopic Remission 33%
• C-reactive Protein 33%
• Endoscopy 33%
• Crohn's Disease 33%
• Delphi Method 33%
• Consensus Conference 33%
• Medical Therapy 33%
• Drug Development 33%
• Index Score 33%
• Gastroenterologist 33%
• Crohn's Disease Activity Index 33%
• Patient Engagement 33%
• Geboes Score 33%
• Mayo Clinic Score 33%
• Stool Frequency 33%
• Interdisciplinary Collaboration 33%
• Likert Scale 33%
• Simple Endoscopic Score for Crohn's Disease 33%
• Trialists 33%
• Methodologists 33%
• Co-primary 33%
• Endoscopic Response 33%
• Core Outcome Measures 33%
• Robarts Histopathology Index 33%
• Colorectal Surgeons 33%
• Fecal Urgency 33%
• Pain Frequency 33%
• Medical Dictionary for Regulatory Activities (MedDRA) 33%

Medicine and Dentistry

• Randomized Controlled Trial 100%
• Ulcerative Colitis 100%
• Crohn's Disease 100%
• Inflammatory Bowel Disease 100%
• Histopathology 50%
• Faecal Calprotectin 50%
• Patient-Reported Outcome 50%
• Abdominal Pain 25%
• Quality of Life 25%
• Surgeon 25%
• Combination Therapy 25%
• Systematic Review 25%
• Biological Marker 25%
• C Reactive Protein 25%
• Endoscopy 25%
• Likert Scale 25%
• Crohn's Disease Activity Index 25%
• Methodologist 25%
• MedDRA 25%